The Truth about Lobbying: AIPAC in Today’s World

AIPAC is small and mighty, but not the monsters they are painted to be.

If you follow political debates on social media, you have probably seen claims that AIPAC is “the biggest lobby in Washington” or that it “spends more than anyone” to influence Congress. These talking points are repeated so often that many people simply assume they must be true. They are not. According to nonpartisan OpenSecrets data, AIPAC ranked 191st among lobbying organizations in 2024, spending roughly $3.3 million — a rounding error compared with Washington’s true big spenders.

AIPAC does lobby. Proudly. Its mission is to advocate for a strong, enduring U.S.-Israel relationship that advances American interests and values. Like other advocacy organizations, it brings constituents and elected officials together around the policy issues its members care about. This is American democracy in action — ordinary citizens exercising their First Amendment right to petition government, just as environmental groups, veterans’ organizations, and business associations do every day.

The “AIPAC is the biggest lobby” myth collapses the moment you look at the numbers. In 2025, the U.S. Chamber of Commerce alone spent more than $70 million on federal lobbying, while the National Association of Realtors spent tens of millions of dollars as well. Health care and pharmaceutical interests routinely top the industry charts, with the pharmaceutical and health products sector spending nearly $300 million on lobbying in 2024. By comparison, AIPAC’s lobbying expenditures are nowhere near the top 20 — or even the top 100.

This pattern is not new. Between 1998 and 2018, AIPAC never cracked the list of the top 50 lobbying organizations. In 2018, its lobbying spending was comparable to companies like International Paper and far below household names such as Alphabet, Facebook, Amazon, and ExxonMobil. The idea that AIPAC dominates Washington through lobbying dollars simply does not withstand comparison with the country’s largest corporate and industry interests.

At the same time, American politics has changed. Campaigns have become more expensive, outside spending has become more consequential, and advocacy groups across the ideological spectrum have built political arms to participate in that environment. AIPAC has had to do the same, creating a PAC and a super PAC to support candidates who share its commitment to the U.S.-Israel relationship. That political activity should not be conflated with its federal lobbying operation; they are separate forms of participation in a political system that increasingly rewards organized electoral engagement.

Even on foreign-policy issues, Israel is not the largest source of foreign lobbying spending in Washington. Public data show that in recent years at least nine other countries — including China, Japan, and Saudi Arabia — have spent more on lobbying than Israel. Those governments, often directly, pay Washington firms millions more each year than all pro-Israel advocacy combined. Yet critics rarely turn those numbers into sweeping claims that “it’s all about the yen” or “all about the riyals.” The double standard is obvious.

So why does the myth persist? Because AIPAC has something money cannot buy: an engaged, organized grassroots base. It empowers pro-Israel Americans — Democrats, Republicans, and independents — to build relationships with their elected officials, stay informed, and support those who support their values. That sustained civic participation, rather than an outsized lobbying budget, helps explain AIPAC’s influence.

People are free to disagree with AIPAC’s positions. That is democracy. But the conversation should be grounded in facts, not caricatures. The reality is that AIPAC is a relatively modest spender in a multibillion-dollar lobbying industry, while also participating openly in the electoral arena that modern American politics has made increasingly important. Its impact comes from committed supporters who are proud to participate in the political process.